Atypical adrenal myelolipoma in patient with resistant hypertension
DOI:
https://doi.org/10.32818/reccmi.a7n2a5Keywords:
adrenocortical adenoma, resistant hypertension, myelolipoma, pheochromocytomaAbstract
Adrenal myelolipoma is a slow-growing tumour, composed of fatty tissue and haematopoietic elements, typically non-secretory, although a low percentage is associated with endocrine pathology.
We present the case of a 35-year-old man who, during the study of resistant arterial hypertension, was diagnosed with a large adrenal incidentaloma with an image congruent with adrenal myelolipoma, whose analytical determinations were anodyne, suggesting a non-functioning adenoma. After surgical resection, the anatomopathological study of the mass revealed pheochromocytoma cells, which produce catecholamines and are responsible for the patient's high blood pressure resistance.
Downloads
Metrics
References
Oliveira Caiafa R, Salvador Izquierdo R, Buñesch Villalba L, Sebastià Cerqueda MC, Nicolau Molina C. Manejo y diagnóstico del incidentaloma suprarrenal. Radiologia. 2011;53(6): 516-30. doi: https://doi.org/10.1016/j.rx.2011.06.006.
Pérez Martínez J, Llamas F, López Rubio E, Serrano A, Salinas Sánchez A, Ruiz Mondéjar R et al. Mielolipoma suprarrenal gigante: hipertensión, insuficiencia renal y rotura espontánea. Nefrologia. 2006; 26(1): 132-5.
Decmann Á, Perge P, Tóth M, Igaz P. Adrenal myelolipoma: a comprehensive review. Endocrine. 2018; 59(1): 7-15. doi: https://doi.org/10.1007/s12020-017-1473-4.
Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, Shen WT et al. Clinical spectrum of pheochromocytoma. J Am Coll Surg. 2009; 209(6): 727-32. doi: https://doi.org/10.1016/j.jamcollsurg.2009.09.022.
Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc. 1981; 56(6): 354-60.
Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1983; 58(12): 802-4.
Baguet JP, Hammer L, Mazzuco TL, Chabre O, Mallion JM, Sturm N et al. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol. 2004; 150(5): 681-6. doi: https://doi.org/10.1530/eje.0.1500681.
Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. 2003; 88(2): 553-8. doi: https://doi.org/10.1210/jc.2002-021251.
Aliasgari M, Ghadian A. Coincidence of angiomyolipoma and pheochromocytoma. Urol J. 2006; 3(1): 61-4. doi: https://doi.org/10.22037/uj.v3i1.217.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 María Toledano, Karen Encalada-Luna, Solsireé Moreno, Enrique Ramón-Botella, Ana Torres-Do Rego, Elena Bello-Martínez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
